Objective: To assess the sex-specific association of adiponectin with multiple factors thought to influence its levels, with a special emphasis on endogenous sex hormones. Design and methods: A cross-sectional study of determinants of serum adiponectin in 873 men and 673 postmenopausal women, ages 50-92. Factors evaluated include age, body size, fat distribution, lifestyle (exercise, smoking, alcohol intake), insulin resistance, renal function and endogenous sex hormone levels (total and bioavailable testosterone and estradiol). Results: Median serum adiponectin was 50% higher in women than men (Po0.001). In unadjusted analyses, adiponectin was positively related to age, alcohol intake, high-density lipoprotein (HDL) and testosterone, and negatively related to waist girth, body mass index, Homeostasis Model Assessment for Insulin Resistance (HOMA-IR), triglycerides and bioavailable estradiol in both sexes (all Po0.01). Adiponectin was positively related to blood urea nitrogen, a measure of renal function, in men only (Po0.001). Sex-specific multivariate linear regressions adjusting for HDL and triglycerides showed that only age, HOMA-IR and sex hormones independently predicted circulating adiponectin for both men and women. Higher levels of endogenous testosterone and lower bioavailable estradiol concentrations each predicted higher adiponectin; this was true for both sexes, and was not explained by differences in age, adiposity, alcohol intake, insulin resistance or lipoprotein levels. Conclusions: The association of adiponectin with the factors studied here is strikingly similar for men and women. Sex differences in circulating adiponectin levels in older adults cannot be explained by sex hormone regulation.
Introduction
There is growing evidence that adipocyte-derived hormones and cytokines may provide a link between obesity and insulin resistance, type 2 diabetes and cardiovascular disease (CVD). 1 The recently identified hormone adiponectin is the most abundant circulating fat-derived protein identified thus far. In contrast to most adipocyte hormones, adiponectin levels are lower in obese individuals and increase with weight loss. 2 Adiponectin is inversely related to both overall and intra-abdominal fat, 3 but is primarily produced by visceral adipose tissue. 4, 5 Low levels of adiponectin have been implicated in the development of a number of obesityrelated conditions, including dyslipidemia, insulin resistance, type 2 diabetes and atherosclerotic heart disease. 6 Circulating adiponectin concentrations are higher in women than men, independent of the fact that women usually have more overall adiposity than men. 5, 7, 8 The biological basis for this sex difference is unknown. One possible explanation is that estrogens increase adiponectin production; however, evidence supporting (or opposing) this hypothesis is limited and contradictory. Three studies have reported the influence of menopause on serum adiponectin: two found no effect, 7, 9 and the other reported higher adiponectin levels in postmenopausal compared to premenopausal women after adjusting for age, fat mass and fat distribution, and an inverse association of adiponectin with estradiol levels. 3 In mice, adiponectin levels are low in the high-estradiol setting of pregnancy, and increase after delivery, whereas ovariectomy results in an increase in plasma adiponectin that is reversed by estradiol treatment. 10 Thus, estrogen may exert a negative, rather than a positive, influence on circulating adiponectin. The sex difference in adiponectin could also be explained by an inhibitory influence of testosterone. Treatment of both sham-operated and castrated male mice with testosterone is accompanied by a reduction in serum adiponectin, and testosterone inhibits adiponectin secretion in cultured adipocytes. 7 Hypogonadal men have higher concentrations of adiponectin than eugonadal men, and levels are lowered to those of eugonadal men by testosterone replacement therapy. 11 A similar inverse pattern is seen in eugonadal men; adiponectin levels increase within days of experimental testosterone deficiency and decrease after supraphysiologic testosterone administration. 12 Low adiponectin levels have also been reported in women with elevated testosterone levels associated with the polycystic ovarian syndrome. [13] [14] [15] To our knowledge, the association of endogenous sex hormone levels with serum adiponectin has not been examined in large epidemiologic studies assessing both sexes.
Other factors, in addition to sex hormones, could be involved in the differential expression of adiponectin in older men and women. It is now well established that adiponectin can act as an insulin sensitizer. 16 It is also possible that insulin or insulin sensitivity at the level of the adipocyte could modulate adiponectin production 16, 17 in a sex-specific manner. In addition, lifestyle choices are known to influence circulating adiponectin concentrations. Sex differences in adiponectin responses to smoking habit, 18, 19 physical activity 20, 21 and/or alcohol intake 19, 22 could explain some of women's higher adiponectin levels.
In this paper, we examine the sex-specific association of adiponectin with lifestyle and other factors thought to influence its levels, including age, body size, fat distribution, lifestyle, insulin resistance, renal function and endogenous sex hormone levels. Data were derived from a cohort of community-dwelling adults who were unselected for prevalent disease. Our goals were to simultaneously assess multiple factors thought to influence adiponectin levels and to identify sex-specific adiponectin associations.
Materials and methods
Between 1984 and 1987, 82% (n ¼ 2548) of surviving men and women from the Rancho Bernardo Study, a communitybased study of healthy aging among middle and uppermiddle class Caucasian adults, participated in a clinic visit. The study protocol was approved by the Institutional Review Board of the University of California, San Diego; all participants gave written informed consent. During this visit, information regarding medical history, medication use, physical activity (exercise 3 þ times per week), alcohol consumption (1 þ drinks/day vs less or none) and current smoking was obtained using standard questionnaires. Women were asked the date of their last menses. Past and current use of estrogen, alone or in combination with a progestin, was ascertained; current estrogen users were excluded from the present study. Current medication use was validated by examination of pills and prescriptions brought to the clinic for that purpose. Height, weight and waist girth were measured in the clinic with participants wearing light clothing and no shoes. Body mass index (BMI) (kg/m 2 ) and waist girth were used as estimates of overall and central adiposity, respectively. Systolic blood pressure was measured twice in seated resting subjects using the Hypertension Detection and Follow-Up Program protocol. 23 Eligibility criteria for this study included (1) evaluation at the 1984-1987 clinic visit, (2) age 50 and older, (3) availability of stored serum, (4) postmenopausal status for women and (5) no estrogen or insulin use at the time of the clinic visit. Of the 2458 participants who attended the 1984-1987 clinic visit, 332 women were excluded for current estrogen use; 1588 (891 men and 697 women) of the remaining participants had sufficient stored sera for measurement of sex hormones and adipocytokines. Of these, 28 were excluded for age less than 50, eight for premenopausal status and nine because of insulin use. Another nine women were excluded from the present analysis because their estradiol levels (4100 pg/ml) suggested unreported estrogen use. Two women and 20 men were excluded because of total testosterone levels outside (4800 pg/ml for the women, o1000 pg/ml for the men) the normal physiologic range.
The remaining 837 men and 673 postmenopausal, nonestrogen using women are the subject of this report.
Blood measures
Steroid hormone levels were measured on first-thawed serum samples between 1992 and 1994 in the endocrinology research laboratory of SSC Yen, University of California, San Diego. Steroid hormones were measured by radioimmunoassay (RIA) after solvent extraction and celite column chromatography; procedural losses were monitored by the addition of tritiated standard to each sample before the extraction step. Bioavailable estradiol and testosterone (the non-sex hormone-binding globulin (SHBG)-bound fractions) were measured by an adaptation of the Tremblay and Dube ammonium-sulfate precipitation method. 24 Adiponectin levels were measured on the same serum samples in 2004 by RIA at Linco Diagnostics Laboratory (St Louis, MO, USA).
Linco reported no problems with two freeze-thaw cycles for the adiponectin assay. The Linco adiponectin assay measures total adiponectin, that is, all molecular forms. The sensitivity and the intra-and interassay coefficients of variation, respectively, were 3 pg/ml, 6 and 7% for estradiol; 3 pg/ml Â percentage free, 6 and 8% for bioavailable estradiol; 20 pg/ml, 4 and 5% for testosterone; 20 pg/ml Â percentage free, 7 and 11% for bioavailable testosterone; and 0.8 mg/l, 6 and 7% for adiponectin. Twenty-six percent (n ¼ 176) of women had estradiol levels below the sensitivity of the assay; estrogen levels below the sensitivity of the assay were assigned the value of the assay sensitivity. Androgen and adiponectin levels for all participants were above the assay sensitivities. Hormone levels did not vary by years of frozen sample storage. 27 The correlation between fasting plasma insulin levels and HOMA-IR was 0.97 for men and 0.96 for women in this cohort; results are presented for HOMA-IR only.
Prevalent diseases
Information on diabetes and CVD history was obtained from standard interview questionnaires. Prevalent CVD was defined as any of the following: myocardial infarction, cardiac revascularization procedure, Rose angina, 28 congestive heart failure, stroke or transient ischemic attack, carotid surgery, peripheral arterial surgery or physician-diagnosed intermittent claudication. Prevalent diabetes was defined by physician diagnosis and/or fasting plasma glucose measurements using 1999 World Health Organization criteria of fasting plasma glucose X126 mg/dl. 29 
Statistical analysis
Data were analyzed using SAS, version 9 (SAS Institute Inc., Cary, NC, USA) and SPSS version 11.5. (SPSS Inc., Chicago, IL, USA). The normality of distribution for continuous variables was tested using the Kolmogorov-Smirnov test. Adiponectin, sex hormones, HDL cholesterol, triglycerides, serum creatinine, BUN and HOMA-IR were not normally distributed and were log (base 10)-transformed for analyses. Reported values for transformed variables are geometric means or medians and interquartile ranges. Sex differences in baseline characteristics were tested by analyses of variance for continuous variables and w 2 tests for categorical variables.
Sex-specific linear regression analyses were used to test the association of demographic, metabolic and lifestyle variables, and sex hormone concentrations with adiponectin levels. Log-transformed adiponectin was modeled as the dependent variable and each other factor as an independent variable. Sex differences in unadjusted adiponectin-factor associations were tested in linear regression models, including both sexes, the pertinent factor and a sex by factor interaction term. Sex-specific multiple linear regression models were used to determine which associations remained significant after adjusting for other variables. Regression diagnostics were performed including tests for collinearity (conservatively defined as tolerance o0.2 or variance inflation factor 45), the influence of outliers (by Cook's distance) and residual plots to assess homogeneity of variance. Biologically plausible interactions (such as age by waist girth) were evaluated; none were found. Standardized b-coefficients (based on z-scores, that is, units of 1 s.d.) are presented for linear regression models to permit comparison of the effects. A two-tailed P-value p0.05 was considered to be statistically significant.
Results

Population characteristics
As shown in Table 1 , men in this study were younger on average than women and had greater BMI and waist girth (all Po0. 001). Total, LDL and HDL cholesterol levels were lower (all Po0.001), and fasting plasma glucose (P ¼ 0.002), HOMA-IR (P ¼ 0.065), BUN (Po0.001) and serum creatinine (Po0.001) higher, in men than women. More men reported consuming one or more alcohol drinks per day than women, more engaged in exercise at least three times per week, and a greater proportion reported prevalent CVD (all Po0.001).
Median adiponectin levels were 50% higher (Po0.001) in women than men (Table 2) . Men had four times higher total and bioavailable estradiol levels than these postmenopausal women, and 20 times more total and bioavailable testosterone (all Po0.001). Adjustment for age, BMI and waist girth did not materially change sex differences, with the exception of HOMA-IR, which became nonsignificant (P ¼ 0.06).
Univariate and age and adiposity-adjusted associations Sex-specific linear regression models with log-transformed adiponectin as the dependent variable and factors thought to influence adiponectin levels as independent variables are shown in Table 3 . In unadjusted analyses, adiponectin levels for both men and women were positively related to age, alcohol intake and testosterone levels, and inversely related to BMI, waist girth, fasting plasma glucose, HOMA-IR and bioavailable levels of testosterone and estradiol. BUN was positively associated with adiponectin in men only; estradiol was inversely associated in women only. Each of these associations remained significant after adjusting for age, BMI and waist girth, with the exceptions of BMI, estradiol and bioavailable testosterone for women, and BUN and bioavailable testosterone for men.
Sex-related interactions were tested in sex-combined models, including the independent variable, sex and a sex by factor interaction term. Of these variables, only age, Endogenous sex hormones and adiponectin GA Laughlin et al alcohol intake and BUN showed a significant sex by factor interaction. Although age had a greater influence on adiponectin in men than women (P for interaction ¼ 0.002), levels remained higher on average in women into the 8th decade of age (Figure 1 ). Adjustment for BUN did not eliminate the sex by age interaction (adjusted P for interaction o0.001). The positive association of alcohol intake with adiponectin was stronger for women than men (P for interaction ¼ 0.008). In analyses adjusted for age and adiposity, adiponectin levels were 7% higher for men (P ¼ 0.04) and 15% higher for women (Po0.001), who reported drinking one or more alcohol beverages per day compared to those who drank less or not at all. After controlling for the effects of age, BMI and waist girth, adiponectin levels were 25% higher (Po0.001) in women than men (adjusted geometric means ¼ 10.71 mg/l for men and 13.30 mg/l for women); additional adjustment for 
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GA Laughlin et al alcohol intake and/or BUN had negligible effect (data not shown).
Multivariable associations
To identify independent predictors of adiponectin, sexspecific multiple linear regression analyses were performed, including age, BMI, waist girth, alcohol intake, total testosterone and bioavailable estradiol. In these analyses, BMI was the only variable that did not significantly contribute to adiponectin levels for either men or women. In a reduced model not including BMI (Table 4 , Model 1), age, alcohol intake and total testosterone were positively, and waist girth and bioavailable estradiol negatively related to adiponectin for both sexes. The influence of insulin resistance was assessed for the subset of 970 consecutive participants for whom HOMA-IR was available. Model 1 results for this subset (shown in Model 2) were almost identical to those for the larger cohort, showing that no bias resulted from restricting the sample to those who had HOMA-IR available. After adjustment for insulin resistance (Model 3, Table 4 ), the magnitude of the association of waist with adiponectin was reduced for women and became insignificant for men. Alcohol intake was also no longer significant for men. The magnitude of age and sex hormone associations were essentially unchanged, and higher HOMA-IR was independently associated with lower adiponectin for both sexes. Results were similar when fasting insulin levels were used instead of HOMA-IR (data not shown).
Serum adiponectin was significantly correlated with HDL and triglycerides for both men (HDL r ¼ 0.46, triglycerides r ¼ À0.43) and women (HDL r ¼ 0.50, triglycerides r ¼ À0.43) (all Po0.001), but was not significantly related to total or LDL cholesterol for either sex (P40.10). Because the adiponectin-lipid association is possibly a downstream consequence of adiponectin action in liver and skeletal muscle, we did not include lipids in analyses aimed at identifying potential sex-specific modulators of serum adiponectin. However, we tested the confounding effect of Endogenous sex hormones and adiponectin GA Laughlin et al HDL and triglycerides on previously identified associations by adding the lipids to the variables in Model 3.
After adjusting for HDL and triglycerides (Model 4, Table 4 ), adiponectin levels for both men and women were significantly related to four factors: age, testosterone, bioavailable estradiol and HOMA-IR. The strength of the associations was attenuated for all variables, with the exception of age. Exclusion of alcohol intake or addition of smoking did not alter Model 4 results, and there was no alcohol by smoking interaction (data not shown). Separate analyses excluding men and women with prevalent diabetes or those with prevalent CVDs yielded similar results for each of the models in Table 4 (data not shown).
Discussion
This study is the first to explore sex differences in adiponectin and its biologic and lifestyle associations in a large population of older, community-dwelling men and women. We confirm results from smaller studies reporting higher serum adiponectin in women than men, independent of body size and fat distribution. Sex-specific multivariate analyses showed that only a few factors were independently associated with circulating adiponectin among these older adults, and these factors were the same for men and women. The most striking finding was that higher levels of endogenous testosterone and lower bioavailable estradiol concentrations each predicted higher adiponectin. This was true for both men and women, and was not explained by age, adiposity, lifestyle, insulin resistance or lipoproteins. The only sex differences identified were the degree to which age, alcohol intake and BUN was related to adiponectin levels.
Why use total testosterone, but bioavailable estradiol, in the multivariate analyses? After adjusting for age and adiposity, only total testosterone and bioavailable estradiol were significantly related to adiponectin levels in both sexes. The importance of the bioavailable fraction of estradiol may be related to the fact that estradiol levels are much lower than testosterone levels in older adults of both sexes. Therefore, binding to SHBG may have a more pronounced effect on overall estradiol activity than it does on testosterone action. In addition, women with upper-body obesity have higher bioavailable estradiol than women with lowerbody obesity, 30, 31 and high bioavailable estradiol predicts insulin resistance in postmenopausal women, independent of the degree of overall and central obesity. 32 Although similar studies are not available for men, bioavailable, but not total, estradiol was correlated with waist girth in the men (r ¼ 0.15, Po0.001) in this study. Thus, it is possible that bioavailable estradiol is an independent marker of an atherogenic profile for both sexes, and that this is the basis for its association with adipocytokine levels.
The positive association of serum testosterone with adiponectin in both sexes was unexpected. Adipocyte culture, animal and human studies consistently point to a suppressive effect of testosterone on serum adiponectin. However, a recent study of 123 Japanese men reported a positive relation between total testosterone levels and serum adiponectin, 33 consistent with our results. The inverse relation between endogenous estrogen and adiponectin has been observed previously in two smaller studies. Adiponectin was inversely associated with estradiol levels in 121 peri-and postmenopausal Greek women, independent of adiposity, 3 and higher levels of the estradiol/SHBG ratio were associated with lower adiponectin in 290 elderly Danish women. 34 To our knowledge, no previous studies have reported an estrogen-adiponectin association in men. Levels of adiponectin are inversely related to the degree of adiposity, and are more closely related to visceral than subcutaneous fat. 5, 35 Endogenous testosterone levels are also inversely related to central adiposity in men in this and other cross-sectional studies, 36, 37 and testosterone therapy in men reduces visceral fat. 38 Thus, the positive association of testosterone with adiponectin in men could be mediated by testosterone effects on the size of the visceral fat mass, rather than a direct effect of testosterone on adiponectin synthesis or secretion. However, central adiposity is generally associated with higher, not lower, testosterone levels in women, 39 total testosterone levels were not significantly correlated with waist girth in the women in this study and adjustment for waist girth did not fully explain the testosterone-adiponectin link in either men or women. Likewise, the negative influence of bioavailable estradiol on adiponectin levels remained significant after adjusting for waist girth, even though bioavailable estradiol levels increased with waist girth in both sexes (men: r ¼ 0.15, women: r ¼ 0.39). As waist girth is only an estimate of visceral adiposity, residual confounding may exist. Lipids and lipoproteins could also explain the testosterone-adiponectin relation. Results of this and other observational studies support experimental evidence that adiponectin promotes HDL formation and reduces triglycerides (reviewed in Chandran et al. 1 and Havel 16 ). Higher levels of testosterone were also significantly correlated with higher HDL and lower triglycerides in this cohort. 39 Adjustment for HDL and triglycerides lowered, but did not eliminate, the positive testosterone-adiponectin associations in either men or women, suggesting that additional mechanisms or factors are involved. The positive association of testosterone and inverse relation of bioavailable estradiol with adiponectin levels found for both sexes are unlikely to explain higher adiponectin levels in women than men. Although levels of bioavailable estradiol were four times higher on average in men compared to women, this is not the case in younger individuals who display the same female advantage in adiponectin levels as seen in these older adults. 40 Based on animal studies, Scherer and colleagues have proposed that
Endogenous sex hormones and adiponectin GA Laughlin et al the sex difference in adiponectin is established very early in life, perhaps through neonatal imprinting of adipocyte or brain function by androgens, and is not dependent on adult sex hormone regulation. 10 However, Bottner et al. 41 have
proposed that the sex difference is established at puberty; adiponectin levels decrease with pubertal development in boys (in parallel with increasing testosterone levels) and are unchanged in girls. The positive association of circulating testosterone and adiponectin levels seen in the present study may only apply to older adults. The age-related increase in adiponectin levels in this cohort was significantly greater for men than women. Cnop et al. 5 reported higher adiponectin levels at older ages for 182 healthy men and women, aged 32-75 years, although they did not observe a sex difference. Other investigators have found significant adiponectin increments with age for men, 33, 42, 43 but four of six reported no age-adiponectin association for women. 7, 33, [42] [43] [44] [45] The differences among these studies may relate to the more modest association of age with adiponectin in women, or to the size and ethnic composition of the study populations.
The adiponectin increment with age could be due to survival bias, that is, those with the highest adiponectin may live the longest, or to age-related differences in adiponectin clearance. The kidneys are thought to be an important site of adiponectin elimination, and several studies have examined the association of renal function with adiponectin levels in healthy populations. One Japanese study reported weak positive correlations between adiponectin and serum creatinine and BUN in 352 women, 45 whereas another reported positive relations for BUN, but not creatinine, in both sexes. 33 Calculated glomerular filtration rate was inversely related to adiponectin in a group of 125 Polish men and women when analyzed together; however, serum creatinine did not contribute significantly to adiponectin levels in sexspecific multivariate analyses. 46 In this cohort, evidence that age-related deterioration of kidney function contributes to higher circulating levels in older adults was weak; adiponectin was not related to serum creatinine in either sex, before or after adjusting for covariates, and was associated with BUN in men only. In addition, adjustment for BUN levels did not account for the more pronounced increment in adiponectin with age in men than women. The observation that insulin sensitivity is strongly positively associated with adiponectin levels extends a previous report by Cnop et al., 5 who concluded that adiponectin was related to insulin resistance, independent of central adiposity. In the present study with relatively few obese adults, adjustment for HOMA-IR in addition to sex hormones explained the association of central obesity (waist girth) with adiponectin in men, but not in women. The direction of these associations is not known. That adiponectin effects insulin-sensitivity is well established by animal studies; 6 however, evidence for the reverse is also available. Insulin inhibits adiponectin gene expression 47 and secretion 4 in cultured adipocytes, and insulin-resistant women secrete less adiponectin from adipose tissue than women with high insulin sensitivity. 48 Thus, insulin action or insulin resistance at the level of the adipocyte may modulate adiponectin levels. Of the lifestyle variables studied, only alcohol intake was related to adiponectin. Consumption of at least one alcoholic beverage daily was associated with 7-15% higher adiponectin levels, and the association was stronger for women than men, in line with a recent experiment showing that alcohol increases adiponectin at lower doses in women than men. 19 In the present study, this association was no longer significant after adjusting for HDL, suggesting that the link between alcohol intake and adiponectin may be confounded or mediated by adiponectin's strong positive association with HDL. Experimental data from Sierksma et al., 22 however, suggest that adiponectin concentrations change independent of HDL levels in response to alcohol intake, and an HDL-independent association of moderate alcohol intake with higher adiponectin was reported for men in the Health Professionals Follow-up Study. 49 Adiponectin levels did not vary by smoking status in this cohort, less than 12% of whom were current smokers. A Japanese study of patients with coronary artery disease reported lower adiponectin levels in both former and current smokers compared to never smokers, independent of adiposity and HOMA-IR. 18 Adiponectin levels were also lower in heavy (10 þ cigarettes/day) compared to moderate or non-smokers in a large German study. 19 Two-thirds of current smokers in Rancho Bernardo reported consuming at least one alcohol beverage daily, thus the positive effect of alcohol intake on adiponectin may have masked any negative effect of smoking in this cohort. Adiponectin was also unrelated to physical activity, consistent with negative results from exercise intervention studies. 20, 21 Although this study is large and considered more covariates in both sexes than previous reports, some limitations should be noted. Because it is cross-sectional, cause and effect cannot be established. As many of the factors studied are derived from or influenced by adipocytes, multiple complex biological interactions are possible, and the potential for unexamined confounding or effect modification is probably high. Our results are more generalizable than many previous studies that were limited by small selected samples or restriction to obese populations, nonetheless they are based on a predominantly white and middle to upper-middle class community and apply to older adults only. Serum adiponectin values were measured on a single sample, which may have limited associations; however, adiponectin levels show minimal diurnal variation, are stable during the morning hours when these samples were collected and single measurements have been shown to accurately reflect levels over a 1-year period. [50] [51] [52] [53] It is not known whether long-term storage effects adiponectin levels; in this cohort, adiponectin concentrations were not significantly related to storage time, and levels were similar to published values for individuals of comparable age and adiposity. 3, 5 Endogenous sex hormones and adiponectin GA Laughlin et al
Adiponectin circulates in complex structures, predominantly a low-and a high-molecular weight (HMW) form. The HMW form is thought to selectively influence glucose homeostasis and endothelial function. 6 The structural regulation of adiponectin seems to be sex-dependent: testosterone selectively inhibits the secretion of the HMW form by adipocytes, 54 and women have higher levels of the HMW form than men. 6 The adiponectin assay used in this study, like all prior large studies, measures total adiponectin, and does not differentiate the molecular forms. In summary, in this cross-sectional study of older community-dwelling adults, endogenous sex hormones did not explain the higher circulating adiponectin levels in women than men. Low testosterone and high bioavailable estradiol concentrations were each associated with low adiponectin, a characteristic of the metabolic syndrome, type 2 diabetes and atherosclerotic heart disease. This sex hormone-adiponectin association was true for both men and women, and was not explained by differences in age, adiposity, lifestyle or insulin resistance. The association of adiponectin with the factors studied here appears to be strikingly similar for the two sexes, with relatively modest sex differences only in the degree of influence of age and alcohol intake on circulating adiponectin levels.
